Applied Clinical Trials
The rapid rise of targeted drugs and biologics in oncology has spurred sponsors and the FDA to innovate, leading to the creation of a variation to the typical trial design that can include multiple expansion cohorts.
Andrew Kinley, Ph.D.
Advertisement
Articles by Andrew Kinley, Ph.D.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The 10 Most Powerful Study KRIs in RBQM and GCP Issues They Can Prevent
2
From Complexity to Endpoint Meaningfulness: Addressing Key Neuroscience Trial Challenges with eCOA
3
Comparing OpenAI and Mistral on Clinical Trial Matching
4
What FDA Inspections Reveal About the Quality of APAC Clinical Trial Sites
5